Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing.
T
T
Schuster
R
R
Linde
U
U
Wintergerst
M B
MB
Funk
M
M
Kurowski
W
W
Kreuz
D
D
Hofmann
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D019888:Nelfinavir / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D011446:Prospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019888:Nelfinavir